v2.3.0.15
Consolidated Statements Of Cash Flows (USD $)
In Thousands
12 Months Ended
Sep. 30, 2011
Sep. 24, 2010
Sep. 25, 2009
Operating activities:   
Net income including controlling interest$ 310,582$ 282,827$ 244,346
Adjustments to reconcile net income to net cash provided by operating activities:   
Depreciation and amortization43,99434,93728,732
Stock-based compensation expense43,665[1]28,815[1]22,422[1]
Amortization of premium on investments17,0889,1185,589
Excess tax benefit from exercise of stock options(6,593)(24,639)(5,827)
Provision for doubtful accounts7723651,392
Losses / (gains) on Put Rights 7,601(9,508)
Losses / (gains) on auction rate certificates (7,601)10,869
Deferred taxes6,784(16,031)5,237
Gain from amended patent licensing agreement  (20,041)
Loss on impairment of long-lived assets22612,986 
Payment on litigation settlement(3,000)(3,000)(3,000)
Other non-cash items affecting net income5323472,151
Changes in operating assets and liabilities:   
Accounts receivable(8,514)(31,329)1,797
Inventories2,105(15,696)(3,638)
Prepaid expenses and other assets(10,305)15,009(147)
Accounts payable and accrued liabilities(16,952)31,556(22,026)
Income taxes, net70827,9958,602
Deferred revenue19,800(25,725)7,488
Other non-current liabilities2,796(237)(1,213)
Net cash provided by operating activities403,688327,298273,225
Investing activities:   
Purchases of available-for-sale securities(619,238)(646,052)(373,223)
Proceeds from sales and maturities of available-for-sale securities and trading securities429,681643,443176,908
Purchases of property, plant and equipment(47,362)(37,482)(13,994)
Purchases of intangible assets (825)(9,571)
Acquisitions, net of cash acquired(3,350)(5,601)(16,621)
Proceeds from sale of property, plant and equipment and assets held for sale3,5672,160 
Net cash used in investing activities(236,702)(44,357)(236,501)
Financing activities:   
Payments on debt (7,680)(1,522)
Proceeds from the exercise of stock options17,87735,56913,716
Proceeds from issuance of Class A common stock (Employee Stock Purchase Plan)5,4424,0603,502
Repurchase of common stock(192,410)(241,362) 
Excess tax benefit from the exercise of stock options6,59324,6395,827
Net cash provided by/(used in) financing activities(162,498)(184,774)21,523
Effect of foreign exchange rate changes on cash and cash equivalents1,163(3,984)(1,330)
Net increase in cash and cash equivalents5,65194,18356,917
Cash and cash equivalents at beginning of year545,861451,678394,761
Cash and cash equivalents at end of year551,512545,861451,678
Supplemental disclosure:   
Cash paid for income taxes122,531141,800113,142
Cash paid for interest$ 375$ 671$ 845
[1]We also recognized $0.7 million, $1.2 million, and $0.3 million in fiscal 2009, 2010, and 2011, respectively, of tax benefit from certain exercises of incentive stock options and shares issued under our ESPP, which is not included in the table above.